Record overview
Status and phase
Status: UNKNOWN
Phase: PHASE2
Sponsor: Amsterdam UMC, location VUmc
Condition: Non Small Cell Lung Cancer
NCT03065764
89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Unknown Status Signal
Timeline signals: stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.